Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.305
-0.005 (-1.58%)
At close: Nov 22, 2024, 4:00 PM
0.304
-0.001 (-0.43%)
After-hours: Nov 22, 2024, 4:22 PM EST

Cara Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1740577651754752
Upgrade
Market Cap Growth
-81.41%-92.99%-11.37%-13.64%0.26%46.64%
Upgrade
Enterprise Value
19-35400462626507
Upgrade
Last Close Price
0.310.7410.7412.1815.1316.11
Upgrade
PE Ratio
----89.65-
Upgrade
PS Ratio
1.921.9313.7828.285.5837.82
Upgrade
PB Ratio
23.670.713.632.863.034.03
Upgrade
P/TBV Ratio
23.890.713.632.863.034.03
Upgrade
EV/Sales Ratio
2.15-9.5520.054.6425.52
Upgrade
EV/EBITDA Ratio
----111.96-
Upgrade
EV/EBIT Ratio
----116.31-
Upgrade
Debt / Equity Ratio
62.230.760.010.020.020.02
Upgrade
Debt / EBITDA Ratio
----0.79-
Upgrade
Asset Turnover
0.100.140.200.090.540.09
Upgrade
Inventory Turnover
16.2343.6439.46---
Upgrade
Quick Ratio
4.324.096.399.559.903.66
Upgrade
Current Ratio
4.774.547.209.8410.553.86
Upgrade
Return on Equity (ROE)
-221.25%-109.80%-44.25%-37.12%3.86%-66.41%
Upgrade
Return on Assets (ROA)
-61.79%-49.30%-25.49%-21.49%1.34%-32.94%
Upgrade
Return on Capital (ROIC)
-74.81%-58.20%-27.92%-22.94%1.51%-43.00%
Upgrade
Earnings Yield
-570.76%-292.78%-14.81%-13.58%1.12%-14.15%
Upgrade
FCF Yield
-462.12%-233.34%-13.65%-9.23%-0.77%-14.53%
Upgrade
Buyback Yield / Dilution
-1.28%-0.92%-5.79%-5.85%-12.29%-18.88%
Upgrade
Total Shareholder Return
-1.28%-0.92%-5.79%-5.85%-12.29%-18.88%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.